NCCN指南®洞察:多发性骨髓瘤,第1.202525版本
Shaji K Kumar1, Natalie S Callander2, Kehinde Adekola3
1Mayo Clinic Comprehensive Cancer Center.
概括
关于多发性骨髓瘤的NCCN指南 (MM) 1.2025版本为新诊断和复发性多发性骨髓瘤的诊断和治疗提供了最新的建议. 这些见解重点关注系统治疗的关键变化,改善患者护理.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 临床实践指南 临床实践指南
背景情况:
- 多发性骨髓瘤 (MM) 是一种复杂的血液恶性瘤,需要更新治疗策略.
- 国家综合癌症网络 (NCCN) 准则是MM管理的关键资源.
- 1.2025版本结合了MM治疗的最新进展.
研究的目的:
- 总结了NCCN多发性骨髓瘤指南 (1.2025版本) 中的主要更新.
- 突出特别与MM的全身治疗相关的变化.
- 告知临床医生关于MM护理最新的基于证据的建议.
主要方法:
- 对多发性骨髓瘤的NCCN指南的审查,版本1.2025.
- 识别和综合与全身治疗有关的变化.
- 专注于对新诊断的MM患者和以前接受过治疗的MM患者的建议.
主要成果:
- NCCN指南1.2025版本包括对全身疗法方案的重大更新.
- 这些更新针对MM的不同阶段和治疗线的治疗方法.
- 具体的变化影响了新诊断和复发/耐药MM的管理.
结论:
- 临床医生应查阅NCCN指南1.2025版本,以了解当前MM治疗标准.
- 遵守最新的指导方针可确保MM患者最佳使用全身疗法.
- 这些修订反映了多发性骨髓瘤治疗的不断变化的格局.
更多相关视频
09:41An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
Published on: July 15, 2015
8.6K
07:24Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos
Published on: December 13, 2018
6.3K
相关概念视频
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Differentiation of Common Myeloid Progenitor Cells
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
